Skip to main content
. 2019 May 24;5:JGO.18.00173. doi: 10.1200/JGO.18.00173

FIG A1.

FIG A1

Patient disposition. (*) Patients who discontinued palbociclib (PAL) or placebo (PCB) could continue to receive letrozole (LET) alone. AE, adverse event; GDHS, global deterioration of health status; PD, progressive disease.